Title: 
Official Title: To amend title XVIII of the Social Security Act to ensure appropriate
            cost-sharing for chronic care drugs under Medicare part D.
Number of Sections: 2
Source: versions - Introduced in Senate
Media Type: text/xml

================================================================================

Section 1:
1.
            Short title
 This Act may be cited as the Share the Savings with Seniors Act.

Section 2:
2.
            Appropriate cost-sharing for chronic care drugs under Medicare part D
            
                (a)
                In general
 Section 1860D–2 of the Social Security Act (42 U.S.C. 1395w–102) is amended—
                
                    (1)
 in subsection (b)—  (A) in paragraph (1)(A), in the matter preceding clause (i), by striking and (9) and inserting , (9), and (10);
                    
                    
                        (B)
 in paragraph (2)(A), in the matter preceding clause (i), by striking and (9) and inserting , (9), and (10); and
                    
                    
                        (C)
 by adding at the end the following new paragraph:   (10) Cost-sharing for chronic care drugs  (A) In general For plan years beginning on or after January 1, 2027, in the case of a chronic care drug, the following shall apply:
                                    
                                        (i)
 For costs below the annual deductible specified in paragraph (1), cost-sharing for such drug shall not exceed the net price of such drug.
                                    
                                    
                                        (ii)
 Subject to subparagraph (B), for costs above the annual deductible specified in paragraph (1) and below the out-of-pocket threshold specified in paragraph (4), any coinsurance amount for such drug shall be based on a percentage of the net price of such drug. 
                                    
                                
                                
                                    (B)
                                    Exception
 The requirement under subparagraph (A)(ii) shall not apply to a chronic care drug under a prescription drug plan if the cost-sharing amount for such drug under such plan is based on a copayment that is not tied to a percentage of a drug price (such as the negotiated price, list price, or wholesale acquisition cost), a drug benchmark price (such as the average wholesale price), or a drug cost.
                                
                                
                                    (C)
                                    Definitions
 In this paragraph:  (i) Chronic care drug The term chronic care drug means a covered part D drug that is included under any of the following United States Pharmacopeia Convention (USP) categories and classes of drugs, as included in the most recent version of the USP Medicare Model Guidelines:
                                        
                                            (I)
 Blood glucose regulators, other than insulins.
                                        
                                        
                                            (II)
 Anti-inflammatories, inhaled corticosteroids.
                                        
                                        
                                            (III)
 Bronchodilators, anticholinergic.   (IV) Bronchodilators, sympathomimetic.
                                        
                                        
                                            (V)
 Respiratory tract agents, other.   (VI) Anticoagulants.
                                        
                                        
                                            (VII)
 Cardiovascular agents, other.   (VIII) Any category or class identified by the Secretary or USP as a successor to the categories and classes described in subclauses (I) through (VII) based on the most recent USP Medicare Model Guidelines at the time of such identification.
                                        
                                    
                                    
                                        (ii)
                                        Net price
 The term net price means the negotiated price of the drug net of all price concessions originating from manufacturers that are received or expected to be received by the plan or pharmacy benefit manager on behalf of the plan for such product and that are not already reflected in the negotiated price.
                                    
                                
                            
                            ; and
                        
                    
                
                
                    (2)
 in subsection (c), by adding at the end the following new paragraph:
                    
                        
                            (7)
                            Cost-sharing for covered chronic care drugs
 The coverage is provided in accordance with subsection (b)(10).
                        
                        .
                    
                
            
            
                (b)
                Conforming amendments to cost-Sharing for low-Income individuals
 Section 1860D–14(a)(1)(D)(iii) of the Social Security Act (42 U.S.C. 1395w–114(a)(1)(D)(iii)) is amended by adding at the end the following new sentence: For plan year 2027 and subsequent plan years, the copayment amount applicable under the first sentence of this subclause for a chronic drug (as defined in section 1860D–2(b)(10)(B)) furnished to the individual may not exceed the applicable cost-sharing for such drug under the prescription drug plan or MA–PD plan in which the individual is enrolled..
            
            
                (c)
                Regulations
 Notwithstanding any other provision of law, the Secretary of Health and Human Services shall initially implement the amendments made by this section through interim final regulations.


================================================================================

Raw Text:
119 S2770 IS: Share the Savings with Seniors Act
U.S. Senate
2025-09-11
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.



        II
        119th CONGRESS
        1st Session
        S. 2770
        IN THE SENATE OF THE UNITED STATES
        
            September 11, 2025
            Mr. Cornyn (for himself, Ms. Rosen, Mr.
                    Tillis, and Mr. Welch)
                introduced the following bill; which was read twice and referred to the
                    Committee on
                Finance
        
        A BILL
        To amend title XVIII of the Social Security Act to ensure appropriate
            cost-sharing for chronic care drugs under Medicare part D.
    
    
        
            1.
            Short title
 This Act may be cited as the Share the Savings with Seniors Act.
        
        
            2.
            Appropriate cost-sharing for chronic care drugs under Medicare part D
            
                (a)
                In general
 Section 1860D–2 of the Social Security Act (42 U.S.C. 1395w–102) is amended—
                
                    (1)
 in subsection (b)—  (A) in paragraph (1)(A), in the matter preceding clause (i), by striking and (9) and inserting , (9), and (10);
                    
                    
                        (B)
 in paragraph (2)(A), in the matter preceding clause (i), by striking and (9) and inserting , (9), and (10); and
                    
                    
                        (C)
 by adding at the end the following new paragraph:   (10) Cost-sharing for chronic care drugs  (A) In general For plan years beginning on or after January 1, 2027, in the case of a chronic care drug, the following shall apply:
                                    
                                        (i)
 For costs below the annual deductible specified in paragraph (1), cost-sharing for such drug shall not exceed the net price of such drug.
                                    
                                    
                                        (ii)
 Subject to subparagraph (B), for costs above the annual deductible specified in paragraph (1) and below the out-of-pocket threshold specified in paragraph (4), any coinsurance amount for such drug shall be based on a percentage of the net price of such drug. 
                                    
                                
                                
                                    (B)
                                    Exception
 The requirement under subparagraph (A)(ii) shall not apply to a chronic care drug under a prescription drug plan if the cost-sharing amount for such drug under such plan is based on a copayment that is not tied to a percentage of a drug price (such as the negotiated price, list price, or wholesale acquisition cost), a drug benchmark price (such as the average wholesale price), or a drug cost.
                                
                                
                                    (C)
                                    Definitions
 In this paragraph:  (i) Chronic care drug The term chronic care drug means a covered part D drug that is included under any of the following United States Pharmacopeia Convention (USP) categories and classes of drugs, as included in the most recent version of the USP Medicare Model Guidelines:
                                        
                                            (I)
 Blood glucose regulators, other than insulins.
                                        
                                        
                                            (II)
 Anti-inflammatories, inhaled corticosteroids.
                                        
                                        
                                            (III)
 Bronchodilators, anticholinergic.   (IV) Bronchodilators, sympathomimetic.
                                        
                                        
                                            (V)
 Respiratory tract agents, other.   (VI) Anticoagulants.
                                        
                                        
                                            (VII)
 Cardiovascular agents, other.   (VIII) Any category or class identified by the Secretary or USP as a successor to the categories and classes described in subclauses (I) through (VII) based on the most recent USP Medicare Model Guidelines at the time of such identification.
                                        
                                    
                                    
                                        (ii)
                                        Net price
 The term net price means the negotiated price of the drug net of all price concessions originating from manufacturers that are received or expected to be received by the plan or pharmacy benefit manager on behalf of the plan for such product and that are not already reflected in the negotiated price.
                                    
                                
                            
                            ; and
                        
                    
                
                
                    (2)
 in subsection (c), by adding at the end the following new paragraph:
                    
                        
                            (7)
                            Cost-sharing for covered chronic care drugs
 The coverage is provided in accordance with subsection (b)(10).
                        
                        .
                    
                
            
            
                (b)
                Conforming amendments to cost-Sharing for low-Income individuals
 Section 1860D–14(a)(1)(D)(iii) of the Social Security Act (42 U.S.C. 1395w–114(a)(1)(D)(iii)) is amended by adding at the end the following new sentence: For plan year 2027 and subsequent plan years, the copayment amount applicable under the first sentence of this subclause for a chronic drug (as defined in section 1860D–2(b)(10)(B)) furnished to the individual may not exceed the applicable cost-sharing for such drug under the prescription drug plan or MA–PD plan in which the individual is enrolled..
            
            
                (c)
                Regulations
 Notwithstanding any other provision of law, the Secretary of Health and Human Services shall initially implement the amendments made by this section through interim final regulations.